CVS Health joins Quit big Tobacco campaign

World |  News | 0 Comment | 02 May, 2019

CVS Health, a US based premier health innovation company as well as the 7th largest company in the United States in terms of revenue, has pledged not to work with advertising...Read more

Abbott announces partnership with DoD

World |  News | 0 Comment | 03 May, 2019

Abbott has announced the next phase of partnership with the U.S. Department of Defense (DoD) and researchers from the Transforming Research and Clinical Knowledge in&nbs...Read more

NHS England partners with Gilead, Merck & AbbVie to eliminate Hep C

World |  News | 1 Comment | 01 May, 2019

The NHS will find and cure tens of thousands more people with hepatitis C as part of a ground-breaking deal that could help England become the first country in the world to eliminate the de...Read more

UN calls for urgent action to avert antimicrobial resistance crisis

World |  News | 0 Comment | 30 Apr, 2019

UN, international agencies and experts has released a groundbreaking report demanding immediate, coordinated and ambitious action to avert a potentially disastrous drug-resistance...Read more

Philips introduces VitalMinds to help reduce delirium in the ICU

World |  News | 0 Comment | 30 Apr, 2019

Royal Philips, a global leader in health technology has introduced VitalMinds, an integrated multi-component solution focused on supporting hospitals with a non-pharmacological approac...Read more

USFDA accepts NDA and grants priority review for Bayer’s darolutamide

World |  News | 0 Comment | 29 Apr, 2019

Bayer announced the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) and granted Priority Review to darolutamide for the treatment of non-metastatic castr...Read more

IQVIA changing healthcare with AI, ML

World |  News | 0 Comment | 29 Apr, 2019

With IQVIA AI & machine learning, one can move with precision, speed and scale across every phase of a product’s lifecycle. These industry-leading technologies are driven by the t...Read more

ACADIA Pharma initiates Ph3 CLARITY Program with Pimavanserin for MDD

World |  News | 0 Comment | 26 Apr, 2019

ACADIA Pharmaceuticals, a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system (C...Read more

Illumina reports financial results for first quarter of FY 2019

World |  News | 0 Comment | 26 Apr, 2019

Illumina has announced its financial results for the first quarter of fiscal year 2019. First quarter 2019 results: Revenue of $846 million, an 8% increase compared to $782 million...Read more

Teva Pharmaceuticals issues voluntary nationwide recall of Losartan Potassium

World |  News | 0 Comment | 26 Apr, 2019

Teva Pharmaceuticals USA, Inc. has initiated a voluntary recall in the United States, to the patient level, of 35 lots of bulk Losartan Potassium USP Tablets (6 lots of 25 mg strength and 2...Read more

Cell Microsystems receives NIH grants worth $1.9M for automating CRISPR workflows

World |  News | 0 Comment | 29 Apr, 2019

Cell Microsystems, a provider of innovative tools for single cell research has announced that it has received two NIH Small Business Innovation and Research awards totaling $1.9M to automat...Read more

BioInvent receives €0.75 M under Mitsubishi Tanabe Pharma partnership

World |  News | 0 Comment | 26 Apr, 2019

BioInvent International has announced that it has received a €0.75 million milestone payment under its collaboration with Mitsubishi Tanabe Pharma Corporation in connection with e...Read more

Tableu, Mapbox, Exasol and Alteryx commit $4.3 M to accelerate malaria elimination efforts

World |  News | 0 Comment | 25 Apr, 2019

Tableau, Mapbox, Exasol, and Alteryx has announced a collective $4.3 million technology contribution over the next three years to help governments eliminate malaria for an estimated 60...Read more

Start Codon to deliver premier life science and healthcare business acceleration program

World |  News | 0 Comment | 25 Apr, 2019

Start Codon, a new strategic initiative aimed at driving the translation of world-class research into commercially successful companies, has been founded and launched with funding from keys...Read more

AbbVie expands immunology portfolio in the U.S. with FDA approval of SKYRIZI™

World |  News | 0 Comment | 25 Apr, 2019

AbbVie , a research-based global biopharmaceutical company has announced that the U.S. Food and Drug Administration (FDA) approved SKYRIZI™ (risankizumab-rzaa), an interleukin-23 (IL-...Read more

Glenmark receives approval to market Momate Rhino metered nasal spray

World |  News | 0 Comment | 25 Apr, 2019

Glenmark Pharmaceuticals has announced that it has received approval from the Ministry of Healthcare, Russia to market Momate Rhino (Mometasone Furoate 50 mcg) metered nasal spray as an ove...Read more

Malaria vaccine pilot launched in Malawi

World |  News | 0 Comment | 24 Apr, 2019

WHO welcomes the Government of Malawi’s launch of the world’s first malaria vaccine in a landmark pilot programme. The country is the first of three in Africa in which the vacci...Read more

Recovery Force receives $1.8M grant from NIH

World |  News | 0 Comment | 24 Apr, 2019

Recovery Force, LLC, a med tech innovation company, has received a $1.8 million grant from the National Institutes of Health (NIH) to complete development and clinically validate its flagsh...Read more